Canada - English - Health Canada

schering-plough canada inc - tolnaftate - aerosol - 1% - tolnaftate 1% - thiocarbamates

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - talazoparib as tosylate - hard capsule - talazoparib as tosylate 0.25 mg - talazoparib - talzenna is indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (brca) mutated (gbrcam) human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - talazoparib as tosylate - hard capsule - talazoparib as tosylate 1 mg - talazoparib - talzenna is indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene (brca) mutated (gbrcam) human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - risedronate sodium hemi-pentahydrate (unii: hu2yaq274o) (risedronic acid - unii:km2z91756z), risedronate sodium monohydrate (unii: f67l43ut5c) (risedronic acid - unii:km2z91756z) - risedronate sodium anhydrous 30.1 mg - risedronate sodium is indicated for the treatment of osteoporosis in postmenopausal women. in postmenopausal women, risedronate sodium has been shown to reduce the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1) ].  the optimal duration of use has not been determined. the safety and effectiveness of risedronate sodium for the treatment of osteoporosis are based on clinical data of one year duration. all patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use. patients who discontinue therapy should have their risk for fracture re-evaluated periodically. risedronate sodium is contraindicated in patients with the following conditions: - abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see warnings and precautions (5.2) ] -

Israel - English - Ministry of Health

megapharm ltd - cholic acid - hard capsule - cholic acid 250 mg - cholic acid - • cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, ctx) deficiency, • 2- (or alfa - ) methylacyl-coa racemase (amacr) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• cholesterol 7 alfa - hydroxylase (cyp7a1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• 3β-hydroxy-5-c27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-c27-steroid dehydrogenase/isomerase or 3β-hsd or hsd3β7.

Israel - English - Ministry of Health

megapharm ltd - cholic acid - hard capsule - cholic acid 50 mg - cholic acid - •cholbam is indicated for the treatment of inborn errors in primary bile acid synthesis due to sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, ctx) deficiency, • 2- (or alfa - ) methylacyl-coa racemase (amacr) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• cholesterol 7 alfa - hydroxylase (cyp7a1) deficiency in infants, children and adolescents aged 1 month to 18 years and adults• 3β-hydroxy-5-c27-steroid oxidoreductase deficiency (also known as 3β-hydroxy-5-c27-steroid dehydrogenase/isomerase or 3β-hsd or hsd3β7.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

delorbis pharmaceuticals ltd. - levocetirizine (levocetirizine dihydrochloride) - tablets film-coated - 5mg

Malta - English - Medicines Authority

resolution chemicals limited - hydrocortisone - tablet - hydrocortisone 10 mg - corticosteroids for systemic use

Malta - English - Medicines Authority

resolution chemicals limited - hydrocortisone - tablet - hydrocortisone 20 mg - corticosteroids for systemic use

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ranbaxy (malaysia) sdn. bhd. - escitalopram oxalate -